In the US, Guanabenz (guanabenz systemic) is a member of the drug class antiadrenergic agents, centrally acting and is used to treat High Blood Pressure.
US matches:
- Guanabenz
- Guanabenz
- Guanabenz Acetate
Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0005051-62-7
Chemical Formula
C8-H8-Cl2-N4
Molecular Weight
231
Therapeutic Category
Antihypertensive agent
Chemical Name
Hydrazinecarboximidamide, 2-[(2,6-dichlorophenyl)methylene]-
Foreign Names
- Guanabenzum (Latin)
- Guanabenz (German)
- Guanabenz (French)
- Guanabenzo (Spanish)
Generic Names
- Guanabenz (OS: DCIT, DCF, USAN)
- BR 750 (IS)
- GBZ (IS)
- SD 15468 (IS)
- Wy 8678 (IS)
- Guanabenz Acetate (OS: USAN)
- FLA 137 (IS)
- Guanabenz Acetate (PH: USP 32, JP XIV)
Brand Names
- Guanabenz Acetate
Sandoz, United States; Teva USA, United States; Watson, United States - Lisapres
Libbs, Brazil - Wytens
Alfresa Pharma Corporation, Japan
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment